WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011145051) NEW USES OF OXYTOCIN-LIKE MOLECULES AND RELATED METHODS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/145051    International Application No.:    PCT/IB2011/052156
Publication Date: 24.11.2011 International Filing Date: 17.05.2011
IPC:
A61K 38/11 (2006.01), A61P 3/10 (2006.01), A61P 3/04 (2006.01)
Applicants: UNIVERSITÉ DE GENÈVE [CH/CH]; 24, rue du Général-Dufour CH-1211 Geneva 4 (CH) (For All Designated States Except US).
ROHNER-JEANRENAUD, Françoise [CH/CH]; (CH) (For US Only).
DEBLON, Nicolas [FR/FR]; (FR) (For US Only)
Inventors: ROHNER-JEANRENAUD, Françoise; (CH).
DEBLON, Nicolas; (FR)
Agent: REUTELER & CIE SA; Chemin de la Vuarpillière 29 CH-1260 Nyon (CH)
Priority Data:
61/447,103 28.02.2011 US
61/345,616 18.05.2010 US
Title (EN) NEW USES OF OXYTOCIN-LIKE MOLECULES AND RELATED METHODS
(FR) NOUVELLES UTILISATIONS DE MOLÉCULES DE TYPE OXYTOCINE ET PROCÉDÉS ASSOCIÉS
Abstract: front page image
(EN)The present invention is directed to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful for the treatment of a disorder selected from obesity and insulin resistance and related methods and pharmaceutical formulations. In particular, the invention relates to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful in the treatment of metabolic syndrome.
(FR)La présente invention concerne un dérivé choisi parmi l'oxytocine, un dérivé d'oxytocine, et un agoniste de l'oxytocine utile pour le traitement d'un trouble choisi parmi l'obésité et la résistance à l'insuline. La présente invention concerne en outre des procédés apparentés et des formulations pharmaceutiques. La présente invention concerne en particulier un dérivé choisi parmi l'oxytocine, un dérivé d'oxytocine, et un agoniste de l'oxytocine utile dans le traitement du syndrome métabolique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)